Updates are available Correction dated 2024-03-13
Click to view Correction: https://doi.org/10.1186/s12954-024-00968-1
-
Authors
Qureshi, Maria Ahmed
Vernooij, Robin W. M.
La Rosa, Giusy Rita Maria
Polosa, Riccardo
O’Leary, Renee
-
Funding
Funding for this research was provided by:
Università di Catania (1355 2020, 1355 2020, 1355 2020)
Foundation for a Smoke-Free World
- License Information
-
More Information
Article History
Received: 24 October 2022
Accepted: 24 September 2023
First Online: 4 October 2023
Change Date: 13 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12954-024-00968-1
Declarations
:
: Not applicable.
: Not applicable.
: GL and RV declare no conflict of interest. RO is supported by a contract with ECLAT; Srl. ECLAT has received funding from the Foundation for a Smoke-Free World. She declares no conflicts of interest. MQ has received a grant from Foundation for a Smoke-Free World outside the submitted work. She declares no conflict of interest. RP has received lecture fees and research funding from Pfizer, GlaxoSmithKline, CV Therapeutics, NeuroSearch A/S, Sandoz, MSD, Boehringer Ingelheim, Novartis, Duska Therapeutics, and Forest Laboratories. He has served as a consultant for Pfizer, Global Health Alliance for treatment of tobacco dependence, CV Therapeutics, Boehringer Ingelheim, Novartis, Duska Therapeutics, ECITA (Electronic Cigarette Industry Trade Association, in the UK), Arbi Group Srl., and Health Diplomats. He has served on the Medical and Scientific Advisory Board (MSAB) of Cordex Pharma, Inc., CV Therapeutics, Duska Therapeutics Inc, Pfizer, and PharmaCielo. Lecture fees from a number of European EC industry and trade associations (including FIVAPE in France and FIESEL in Italy) were directly donated to vaper advocacy non-profit organizations. RP is the founder of the Center for Tobacco prevention and treatment (CPCT) at the University of Catania and the Center of Excellence for the acceleration of Harm Reduction (CoEHAR) at the same University, which has received support from Foundation for a Smoke Free World to conduct 8 independent investigator-initiated research projects on harm reduction. RP is currently involved in the following pro bono activities: scientific advisor for LIAF, Lega Italiana Anti Fumo (Italian acronym for Italian Anti-Smoking League), the Consumer Advocates for Smoke-free Alternatives (CASAA) and the International Network of Nicotine Consumers Organizations (INNCO); Chair of the European Technical Committee for standardization on “Requirements and test methods for emissions of electronic cigarettes” (CEN/TC 437; WG4).
